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Abstract
DiGeorge syndrome (DGS) is the most common microdeletion syndrome, and is characterized by congenital cardiac,
craniofacial and immune system abnormalities. The cardiac defects in DGS patients include conotruncal and ventricular
septal defects. Although the etiology of DGS is critically regulated by TBX1 gene, the molecular pathways underpinning
TBX1’s role in heart development are not fully understood. In this study, we characterized heart defects and downstream
signaling in the zebrafish tbx12/2 mutant, which has craniofacial and immune defects similar to DGS patients. We show that
tbx12/2 mutants have defective heart looping, morphology and function. Defective heart looping is accompanied by failure
of cardiomyocytes to differentiate normally and failure to change shape from isotropic to anisotropic morphology in the
outer curvatures of the heart. This is the first demonstration of tbx1’s role in regulating heart looping, cardiomyocyte shape
and differentiation, and may explain how Tbx1 regulates conotruncal development in humans. Next we elucidated tbx1’s
molecular signaling pathway guided by the cardiac phenotype of tbx12/2 mutants. We show for the first time that wnt11r
(wnt11 related), a member of the non-canonical Wnt pathway, and its downstream effector gene alcama (activated
leukocyte cell adhesion molecule a) regulate heart looping and differentiation similarly to tbx1. Expression of both wnt11r
and alcama are downregulated in tbx12/2 mutants. In addition, both wnt11r2/2 mutants and alcama morphants have heart
looping and differentiation defects similar to tbx12/2 mutants. Strikingly, heart looping and differentiation in tbx12/2
mutants can be partially rescued by ectopic expression of wnt11r or alcama, supporting a model whereby heart looping and
differentiation are regulated by tbx1 in a linear pathway through wnt11r and alcama. This is the first study linking tbx1 and
non-canonical Wnt signaling and extends our understanding of DGS and heart development.
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Introduction
DiGeorge syndrome (DGS) is the most common microdeletion
syndrome occurring in 1/4000 live births [1]. Approximately 75–
80% of patients have congenital heart disease with conotruncal
defects (Tetralogy of Fallot, aortic arch defects, and truncus
arteriosus) and ventricular septal defects. Other defects include
thymic hypoplasia, palate defects and thyroid and parathyroid
abnormalities. Cardiac defects are the leading cause of mortality in
DGS, but the underlying molecular pathobiology is not well
understood.
Most DGS patients have a 3 Mb or a nested 1.5 Mb deletion of
chromosome 22q11.2 that includes the TBX1 gene. Genetically
engineered mouse mutants have led to the identification of Tbx1 as
the gene responsible for cardiovascular and thymic defects [2,3,4].
Several patients without the chromosomal deletion harbor frame-
shift and missense mutations in TBX1, strongly suggesting that
DGS is caused by haploinsufficiency of TBX1 [5,6]. TBX1 is a
member of a group of transcription factors that are characterized
by the presence of a T-box, a highly conserved DNA-binding
region that also has a conserved interaction domain for other
transcription factors [7]. T-box genes mediate transcriptional
activation and/or repression and are important for embryonic
development and differentiation of all three germ layers [8,9,10].
In addition, T-box genes are extremely dose-sensitive and often
act in a combinatorial or hierarchical fashion [7].
Dose-sensitivity of mouse Tbx1 gene has been tested using
various hypomorphic and null alleles and transgenic models
[3,11,12]. While Tbx1+/2 mice have a milder phenotype,
Tbx12/2 mice have a severe phenotype with single cardiac
outflow tract (OFT), aortic and pharyngeal arch defects, thymus
and parathyroid gland aplasia [2]. Tissue-specific knockdown of
Tbx1 in the pharyngeal endoderm or mesoderm recapitulates the
cardiac defects observed in Tbx12/2 mice and DGS patients,
making it difficult to study the role of Tbx1 separately in different
tissues [13,14]. Previous studies have identified several genes,
including Fgf10, as part of the Tbx1 pathway [12]. However,
validation and detailed description of their roles downstream of
Tbx1 during development is lacking.
While non-canonical Wnt signaling has no known link to Tbx1,
it inhibits b-catenin signaling and promotes its own signaling
through protein kinase C and c-jun terminal kinase during normal
heart morphogenesis [15,16,17,18]. Wnt11, a non-canonical Wnt
member, is required for heart specification and can induce
expression of cardiac genes in Xenopus explants and non-cardiac
cells from humans and mouse [15,19,20,21,22,23,24]. Further-
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more, mutations in Wnt11 cause cardiac OFT defects such as
truncus arteriosus, similar to those observed in Tbx12/2 mutants
[25]. Knockdown of wnt11r, an ortholog of Wnt11 present in
Xenopus, resulted in heart morphology defects and cardia bifida in
some cases [15]. In spite of the similarity in phenotypes caused by
loss of Tbx1 and Wnt11 signaling, no link between these pathways
has been established to date.
The pattern of heart development is conserved through
evolution. Development begins with specification of the bilateral
Primary Heart Fields (PHF) in lateral plate mesoderm. Subsequent
migration towards the midline results in the cardiac crescent and
later the linear heart tube, at which point the heart starts beating.
The tube then undergoes asymmetric looping and morphogenetic
movements to result in the multi-chambered heart. This complex
process involves ballooning of the chamber walls, addition of
cardiomyocytes derived from the Secondary Heart Field (SHF) at
the arterial pole and formation of septa and valves. Formation of
heart chambers is accompanied by differential gene expression
within the heart [18,26]. Cell tracing experiments in mice and
chick have established that heart myocardium derives from PHF,
while SHF contributes to the OFT [27]. Interestingly, previous
studies suggest that Tbx1 is expressed in SHF and that Tbx1
positively regulates SHF cell proliferation and contribution to the
muscle layer of OFT [12,28,29].
This vertebrate pattern of heart development is largely
conserved in zebrafish. Similar to mice and chick, zebrafish PHF
cells migrate towards the midline to form a linear heart tube [30].
Moreover, presence of SHF and its contribution to OFT has been
recently confirmed in zebrafish [31,32]. Zebrafish have a simple
two-chambered heart with a single inflow and outflow tract and
looping results in an S-shaped heart instead of the 4-chambered
heart with multiple outlets in higher vertebrates [30]. The OFT
retains the bulbous arteriosus (BA), an accessory chamber
equivalent to the conus arteriosus of amphibians and reptiles.
This structure has been replaced by the pulmonary and aortic
trunk in mammals and birds [33,34]. The simpler structure of the
heart combined with transparency of embryos and availability of a
tbx1 mutant, make zebrafish the ideal system to study cardiac
defects associated with DGS. Here we use the zebrafish tbx12/2
mutant [35] to study cardiac defects associated with DGS and
identify tbx1 target genes. We show that tbx1 is required for normal
heart looping and differentiation of myocardium derived from the
PHF and SHF. In addition we provide evidence that tbx1 mediates
its function at least in part via wnt11r, and one of its downstream
mediators, alcama.
Materials and Methods
Fish stocks and maintenance
Fish were maintained at 28.5uC under standard conditions [36]
and were staged as described [37]. The vgotm208 (tbx12/2) line and
wnt11r fh224/+ (wnt11r2/2) mutant lines were a kind gift from Dr
Tatjana Piotrowski (Stowers Institute of Medical Research, Kansas
City, MO) and Dr. Cecilia Moens (Fred Hutchinson Cancer
Center, Seattle, WA). Homozygous mutants were obtained by
inbreeding of heterozygous carriers. Tg(cmlc2:EGFP) fish that
express green fluorescent protein (GFP) in the nuclei of
cardiomyocytes under the control of cardiac myocyte light chain
promoter, were a gift from Dr Joseph Yost (Department of
Neurobiology, University of Utah) [38].
Identification and genotyping of mutants
tbx12/2 mutants have an A-to-T missense mutation [35].
Mutant embryos were identified by high resolution melting
analysis [39]. DNA was extracted from the tails of stained
embryos and PCR was conducted using the primers 59-
CACAACTGAAAATCGCCAGCAATC-39 (forward, 0.2 mM),
59- AATATGGTAAAACTCACCAGTCCT -39 (reverse, 1 mM)
and 59- TTTACCAAAGGCTTCAGAGACTGTAATCCC -39
(unlabelled probe complementary to reverse strand, 1 mM). After
PCR, the samples were heated to 94uC for 2 minutes and then
cooled to 10uC before melting. LCGreen dye (Idaho Technology)
was included in the PCR mix and melting analysis was done on
LightScannerTM (Idaho Technology). The wnt11r2/2 mutant was
generated by tilling, and has a G-to-T nonsense mutation that
generates a stop codon at amino acid 94. wnt11r2/2 mutants were
identified in a similar fashion using the primers 59-
GGTCTGCCAAAAGACCTTCACAG-39 (forward, 0.2 mM),
59- TTGGAAATAAATGCGTTTAGACACGGTT-39 (reverse,
1 mM) and 59- TGTTCCCCTATTGATGGACC-
GAAACTCCT-39 (unlabeled probe complementary to reverse
strand, 1 mM). All the identified WT and mutants were included in
the analysis.
Cloning and RNA transcription
The tbx1 gene cloned in pCS2+, and wnt11r gene cloned in
pCMVSport6.1, were obtained from ZIRC (Zebrafish Interna-
tional Resource Center). To make sense RNA for injection, these
plasmids were cut with NotI and XhoI respectively, and in vitro
transcribed from Sp6 promoter using mMessage Machine kit
(Ambion). RNA for alcama was made as previously described [40].
Morpholino antisense oligonucleotide and RNA
injections
Morpholino and RNA were dissolved in molecular biology
grade water and pressure injected into 1–4 cell zebrafish embryos.
For RNA rescue experiments, 26 pg of tbx1, wnt11r or alcama RNA
was injected per embryo. The previously described translation
blocking morpholino for alcama was used at 1.1 ng per embryo
[40].
Tissue labeling procedures
Whole mount RNA in situ hybridization (ISH) with digoxigenin
was performed as previously described [41]. The plasmids for
versican and eln2 were a gift from Dr Joseph Yost (Department of
Neurobiology, University of Utah) and for amhc and vmhc from Dr
Dean Li (Department of Human Genetics, University of Utah).
Alcama protein was stained using Zn-5 antibody from ZIRC at
1:500 dilution. A goat anti-mouse secondary antibody conjugated
with Alexa 555 (Invitrogen) was used for fluorescence labeling of
cell boundaries. For non-fluorescence detection, secondary anti-
body conjugated to alkaline phosphatase (Bio-Rad) was used with
NBT-BCIP (Roche). The Isl-1 antibody was a gift from Dr
Richard Dorsky (Department of Neurobiology and Anatomy,
University of Utah) and was used at 1:100 dilution. Labeling of
bulbous arteriosus with DAF-2DA (VWR) was done as previously
described [42].
Imaging and quantification
Head-on photographs of 48 hours post fertilization (hpf) larvae
were taken on Nikon SMZ1000. Dissected hearts and ISH
embryos were photographed on a Nikon Y-IDP microscope at
206 zoom using Spot software. Confocal images of dissected
hearts were taken on Olympus FV1000 microscope at 406zoom.
Images of all larvae from the same experiment were taken using
the same settings and exposure. Cell numbers were counted using
Imaris software. Measurements for circularity, length and volume
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were done using ImageJ and angles were measured on Adobe
Photoshop. Live embryos were mounted in 1% low melt agarose
and movies of the beating heart were taken with the Nikon Y-IDP
microscope.
Morphometric measurements
Head-on pictures of cmlc2 stained 48 hpf embryos were used for
measuring looping angles. To quantitate the looping angle, we
measured the angle between the longitudinal axes of ventricle and
atrium as shown in schematic Figure S1D. The ventricular axis
was drawn by connecting the midpoint at the dorsal end of the
ventricle (m, where it meets the OFT) and the midpoint at the
widest part of the ventricle in a parallel plane to the dorsal end (n).
Similarly the atrial axis was determined by joining the midpoint at
the ventral end of the atrium (p, where it meets the IFT) and the
midpoint at the widest part of the atrium in a parallel plane to the
ventral end (q). The length of the chambers was determined by
measuring along the longitudinal axes (m-n-o for the ventricle, and
p-q-r for the atrium) with the end point at the bisection of the arc
formed by the boundary of cmlc2 staining near the AVC (o and r,
respectively).
The BA is shaped like a circle sliced horizontally at dorsal and
ventral ends. Width of the BA was measured at the widest part of
the small circular chamber (diameter of the circle). The length was
measured from the ventral end of the cut where it meets the
ventricle, to the dorsal end where it continues as an artery.
Analysis of cardiac performance
Movies of beating hearts were imaged as above and analyzed as
follows. Heart rate was calculated by counting the number of
sequential contractions. The widths of ventricles/atria at diastole
and systole were measured. The width was measured at the widest
part along the anterior-posterior axis. Since the chambers are
prolate spheroids, width measurement along the anterior-posterior
axes in lateral view is equivalent to left-right measurement in a
head-on view. Shortening fractions were calculated as width
[(diastole – systole)/diastole]. Stroke volume was determined as
previously described [43]. The perimeter of the ventricle during
diastole and systole was outlined on ImageJ and analyzed with a
‘‘fit-to-ellipse’’ algorithm, giving the major and minor axes.
Volume was calculated using V=4/3 * p * a * b2, where ‘‘a’’ is
the major axis and ‘‘b’’ the minor axis. The stroke volume was
obtained by subtracting the volume at systole from volume at
diastole.
Paraffin embedding and sectioning
72 hpf larvae were fixed in 4% paraformaldehyde for 2 days,
dehydrated in ethanol series and transferred directly to xylene.
They were allowed to equilibrate for 90 min and then placed in
paraffin. Embryos were embedded in disposable plastic molds and
cooled before sectioning at 5 mm on a Leica RM2155 microtome.
Glass slides were heated to 60uC overnight, placed in xylenes for
5 min, rehydrated through an ethanol series to water, stained with
0.1% toluidine blue, and coverslipped using Cytoseal 60 (Fisher
Scientific).
Ethics statement
This work has been approved by the University of Utah IACUC
(#11-07006). All the fish are housed at the campus fish facility
where, all laboratory personnel are trained for the maintenance
and care of zebrafish. I am trained and certified for handling
zebrafish.
Results
tbx1 is required for normal cardiac looping in zebrafish
In zebrafish, tbx1 expression initiates between 12–14 hpf in the
lateral plate mesoderm containing the cardiac progenitors [35],
and is maintained in the myocardium as the heart develops (Fig.
S1A–C). By 48 hpf, expression is stronger in the ventricle as
compared to the atrium and particularly pronounced in the
atrioventricular canal (AVC) (Fig. S1C). We investigated whether
tbx1 is necessary for correct cardiac morphogenesis in zebrafish,
similar to humans and mice. To that end, we visualized
cardiomyocytes in the tbx12/2 null mutant [35] using cmlc2 in
situ hybridization (ISH). The cardiac progenitors are correctly
specified at 14 somites, migrate towards the midline to fuse at 21
somites and form the linear heart tube at 24 hpf in tbx12/2
mutants. However, jogging of ventricle (30–36 hpf) and looping of
the heart (36–48 hpf), is defective in tbx12/2 mutants resulting in a
straight heart (Fig. 1B) rather than the WT S-shaped heart
(Fig. 1A). The straight heart phenotype was variable between
larvae, so we measured the angle between the longitudinal axes of
ventricle and atrium to quantify the defect (see Experimental
Procedures and Fig. S1D). There is a statistically significant
decrease in the angle between WT (22u) and tbx12/2 mutants (10u)
(Fig. 1C). While the atrioventricular angle and left-right position-
ing of the heart is affected in tbx12/2mutants, the antero-posterior
positioning of the heart is unaffected. Our data demonstrate that
tbx1 is necessary for heart looping.
tbx1 regulates cardiomyocyte shape
Cardiomyocyte shape changes are a major contributor to
normal heart looping [44,45]. During the process of looping, the
cells transition from small and rounded (isotropic) morphology in
the linear heart tube (24–28 hpf) to flattened and elongated
anisotropic cell shapes in the outer curvature at the expanded
chamber stage (48–58 hpf) [46]. We investigated the possibility
that tbx1 regulates the shape of cardiomyocytes, hence affecting
heart looping. To that end, we stained 48 hpf Tg(cmlc2:EGFP)
larvae with Alcama antibody to visualize the cell boundary, and
analyze cell shape. Larvae were co-stained with DAPI to visualize
the nuclei, and hearts were dissected and imaged using a confocal
microscope (Fig. 2A, B). In WT siblings, the cells in the outer
curvature are elongated with their longitudinal axes pointing
towards the AVC (white outline), while cells in the inner curvature
continue to be small and rounded (yellow outline) (Fig. 2A).
However, tbx12/2 mutant cells in the outer and inner curvatures
retain the small and rounded morphology at 48 hpf (Fig. 2B). We
quantified this defect by calculating the circularity of 10 cells from
the inner and outer chambers of 7 mutant and WT embryos. Cells
from tbx12/2 mutants in the outer curvature have 1.2–1.3 fold
higher circularity (are rounder) as compared to WT siblings
(Fig. 2C), while cells in the inner curvature are equally round
between the mutant and WT (Fig. 2D). In summary, our data
suggest that tbx1 is required for regulation of cardiomyocyte shape,
and heart looping defect in tbx12/2 mutants.
tbx1 regulates cardiac morphology and cardiomyocyte
number
In addition to the looping defect, tbx12/2 mutants have other
cardiac morphological defects. Mutant ventricles are significantly
shorter at 48 hpf (Fig. S1E), while atrial length is similar between
mutants and WT. The ventricle at its widest point is significantly
wider in the mutant when compared to WT at 48 hpf, (Fig. S1F)
and 72 hpf (data not shown). Atrium width differences between
mutants and WT are significant at 72 hpf (Fig. S1G), but not at
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48 hpf (data not shown). In addition, sections of the heart at
72 hpf, reveal that mutant hearts have thinner ventricular walls
and larger intercellular spaces (Fig. 1D).
The smaller ventricle size in tbx12/2 mutants may be due either
to fewer or to smaller cardiomyocytes. To distinguish between
these possibilities, we stained tbx12/2; Tg(cmcl2:EGFP) larvae with
DAPI to count total cell numbers in hearts (Fig. S2A,B). Total
cardiomyocyte number was unchanged at 33 hpf, but was
significantly decreased 1.3 fold at 48 hpf (post-looping and
morphological defects) (Fig. S2C). This correlates with the lower
cell density and larger intercellular spaces observed in sections of
tbx12/2 mutant hearts (Fig. 1D). Our data suggests that tbx12/2
mutants have proper specification and differentiation of cardio-
myocytes during early stages marked by cmlc2 expression (Fig. 1A),
but have decreased number of cardiomyocytes during later stages
(after 33 hpf, Fig. S2C).
The late decrease in cardiomyocyte number observed in
tbx12/2 mutants may be caused by decrease in proliferation of
the PHF cells. We tested this possibility by analyzing proliferation
of cardiomyocytes using phosphohistone 3 (PH3) staining to
determine the percentage of cells undergoing mitosis (Fig. S2A, B).
Analysis of PH3 staining reveals that the mean number of
proliferating cells per heart is significantly reduced 1.6 times at
33 hpf (15 in WT siblings versus 9 in tbx12/2 mutants, Fig. S2D).
However, the low percentage of cardiomyocytes undergoing
mitosis (5–8%) combined with the physiologic decrease in cell
proliferation from 24 to 48 hpf [47], suggests that decreased
proliferation in tbx12/2 mutants might be insufficient to drive the
dramatic difference in cardiomyocyte number at 48 hpf (235 in
WT siblings versus 194 in tbx12/2 mutants).
An alternative or additional explanation of reduced cardiomy-
ocyte number in tbx12/2 mutants is reduced contribution of SHF-
derived cells. Recently several groups have reported the existence
of a SHF in zebrafish that contributes cardiomyocytes to the
arterial pole of the heart tube between 24 and 48 hpf [31,32,48].
During the course of our analysis, Hami et al. reported that
tbx12/2 mutants have reduced incorporation of dye-labeled cells
from the pericardial wall to the arterial pole of the heart. Thus the
reduced cardiomyocyte number in tbx12/2 mutants could result
from a combination of decrease in PHF cell proliferation and
decrease in incorporation of SHF cells. Taken together, these data
suggest that tbx1 regulates proliferation of PHF cells and
incorporation of SHF cells into the developing heart. Whether
SHF cell incorporation plays a role in heart looping is an
intriguing possibility and will be a part of future investigations.
tbx1 expression is necessary for regional differentiation of
heart
At 48 hpf the heart becomes differentiated to form the various
regions: inflow tract (IFT), atrium, atrioventricular canal (AVC),
ventricle and OFT. In zebrafish, heart looping defects are highly
correlated with defects in regional differentiation of the heart,
suggesting that these regional changes in expression pattern are
Figure 1. tbx1 expression and heart looping defects in tbx12/2 embryos. (A) cmlc2 ISH in tbx12/2 mutants and WT siblings at specification
(14 somites), fusion (21 somites), linear heart tube (24 hpf), jogging (30–36 hpf) stages. (B) By 48 hpf the heart has finished looping in WT forming an
acute angle between the atrial and ventricular axes (green lines), while in tbx12/2 mutants the axes are nearly parallel. (C) Comparison of atrio-
ventricular axis angles between wild-type (left, green) and tbx12/2 mutants (right, red). N indicates the total number of embryos represented in the
plot. (D) 5 micron sections of the hearts from 72 hpf embryos, showing wider ventricle and atrium and thinner heart walls in tbx12/2 mutant as
compared to WT sibling. Arrows indicate the AVC; a, atrium; v, ventricle. Scale bar: 50 mm.
doi:10.1371/journal.pone.0058145.g001
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important for the looping process [46,49,50,51,52,53]. We
performed ISH analysis in tbx12/2 mutants at 52 hpf to evaluate
if regional differentiation occurs normally. The ventricular marker
vmhc and atrial marker amhc are expressed normally in tbx12/2
mutants, suggesting that atrial and ventricular specification occurs
normally in tbx12/2 mutants (Fig. S3).
We next analyzed expression of markers specific to different
regions of the myocardium. At 52 hpf, bone morphogenetic protein 4
(bmp4) is expressed in the IFT, AVC and OFT in WT siblings
(Fig. 3A), but expression is absent in tbx12/2 mutants (Fig. 3E).
Similarly, WT siblings express versican and notch1b in the AVC
myocardium and endocardium, respectively (Fig. 3B, C). Howev-
er, tbx12/2 mutants fail to express these markers in the AVC at
this stage (Fig. 3F, G). Next, we analyzed atrial natriuretic factor (anf),
whose expression is restricted to the outer curvature of the
ventricle and atrium in WT siblings (Fig. 3D). However, in
tbx12/2 mutants, anf expression is expanded to the inner curvature
in the ventricle and to a lesser degree in the atrium. In order to
determine if these defects are heart specific, we examined versican
expression in the otoliths. tbx12/2 mutant otoliths express versican
(inset Fig. 3G), indicating that tbx1 is required for regional
expression of these markers specifically in the heart.
The abovementioned markers are expressed broadly along the
linear heart tube at 30 hpf, but become restricted to specific
regions by 48 hpf. These markers are expressed normally in the
tbx12/2 mutants at 30 hpf (data not shown), indicating that the
differentiation defect arises later in development, concomitant with
the heart looping and cardiomyocyte shape defects. The differen-
tiation defect may be an effect or a cause of the looping defect. In
addition, penetrance of these defects is not uniform in tbx12/2
mutant larvae (Fig. 3M–P). Alterations in notch1b expression
showed the highest penetrance and we will henceforth use it as a
marker for regional differentiation. Failure of tbx12/2 mutants to
restrict anf expression, taken together with absence of bmp4,
notch1b, and anf, suggests that tbx1 is necessary for regional
differentiation of the heart.
tbx1 is necessary for normal OFT formation and
differentiation
DGS patients and Tbx12/2 mutant mice have defects in OFT
such as persistent truncus arteriosus and interrupted aortic arch.
Hence we studied the OFT in the zebrafish tbx12/2 mutants. The
zebrafish ventricle ends in a constriction leading to the BA, an
accessory chamber present in lower vertebrates that is composed
of smooth muscle. The BA is shaped like a circle sliced horizontally
at the dorsal and ventral ends, where it meets the artery and
ventricle, respectively (Fig. 4A, D; for details of measurement
parameters, please refer to the ‘‘morphometric measurements’’ in
the Materials and Methods section). While BA width is unaffected
(Fig. 4 G), its length is reduced in tbx12/2 mutants versus WT
siblings (Fig. 4H).
In addition to morphology, we analyzed the tbx12/2 mutant for
proper differentiation of the BA. To that end we used the
fluorescent nitric oxide sensor DAF-2DA, a marker for smooth
muscle [42]. Our analysis revealed that BA smooth muscle in
tbx12/2 mutants is defective as evidenced by negative staining
with DAF-2DA (Fig. 4B, E). tbx12/2 mutants also fail to express
the BA-specific marker tropoelastin2 (eln2) at 72 hpf (Fig. 4F). Taken
together, our findings suggest that in the absence of tbx1 signal, the
BA is underdeveloped and undifferentiated. In keeping with our
data, a recent report demonstrated that tbx12/2 mutants have
reduced incorporation of SHF cells at the arterial pole [32], which
may contribute to decreased size of BA.
tbx12/2 mutants have defects in cardiac performance
To determine how the heart looping and differentiation defects
in tbx12/2 mutants affected cardiac function, we analyzed movies
of beating hearts in live embryos at 31, 48 and 72 hpf. Cardiac
contractility was assessed using the ventricular and atrial
shortening fractions. Mean ventricular shortening fraction was
unaffected at 48 hpf but was significantly lower at 72 hpf in
tbx12/2 mutants (0.16060.012) compared to WT (0.19760.014)
(Fig. S4A). In contrast, mean atrial shortening fraction was
unaffected at 48 hpf and 72 hpf (Fig. S4B). As shortening fraction
is a function of width, the unchanged atrial contractility was in
keeping with the weaker morphological defect observed in tbx12/2
mutant atria (Fig. S1E, G). Considering the decreased ventricular
contractility in tbx12/2 mutants, we next assessed the cardiac
output as stroke volume of the ventricle. While the stroke volume
was 10–20% lower in tbx12/2 mutants at both 48 and 72 hpf, this
difference is not statistically significant (p-value .0.05) (Fig. S4C).
The unchanged stroke volume suggests that in spite of decrease in
ventricular length, the mutant heart probably compensates by
increased ventricular width to maintain cardiac output.
In addition to contractility and stroke volume, another
important factor to measure for cardiac performance is the heart
rate. Heart rate was lower in tbx12/2 mutants at both 48 and
72 hpf. At 48 hpf the mean heart rate decreased to 75% in
tbx12/2 mutants (10862 beats per minute) as compared to WT
siblings (14362 beats per minute). At 72 hpf the mutant heart rate
(16762) partially recovered to 86% of WT (19564) (Fig. S4D).
This is in direct contrast to DGS patients where the heart beats
faster to compensate for OFT obstructions. Since zebrafish do not
Figure 2. Cell shape defects in tbx12/2 mutants. (A, B) Confocal
projections of hearts from Tg(cmlc2:EGFP) embryos at 48 hpf stained
with Alcama antibody (red) to demarcate cell boundaries. Cells in the
outer and inner chambers are outlined in white and yellow respectively.
The insets in E and F show a magnified view of the outer curvature cell
outlined in white. The plot in C shows that cells in the outer chamber of
tbx12/2 mutants are rounder (circularity tending towards 1) as
compared to WT. (D) Cell shape is unchanged in the inner chamber
of tbx12/2 mutants. Each bar in plots C and D represents data collected
from 70 cells in 7 different embryos. Arrows point to the AVC; v,
ventricle; a, atrium. Scale bars: 25 mm.
doi:10.1371/journal.pone.0058145.g002
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have any obstruction in the BA, they probably do not need this
compensatory mechanism. In conclusion, the ventricle in tbx12/2
zebrafish mutants has defects in contractility and heart rate, while
stroke volume is unaffected.
wnt11r regulates heart looping and regional
differentiation similar to tbx1
While several genes have been implicated in the tbx1 pathway,
detailed characterization of the tbx1 pathway regulating DGS
phenotype is lacking. We sought to utilize the zebrafish heart
looping defect to identify new genes that may function
downstream of tbx1 during this process. To that end we utilized
a candidate gene approach, and analyzed all genes known to
regulate heart looping and whose misregulation cause cardiac
diseases in humans. Interestingly, T-Box proteins frequently
interact and several among them, such as tbx2a, tbx3b [50], tbx5
[53], and tbx20 [54], have been implicated in zebrafish heart
looping. Furthermore, mutations in TBX5 and TBX20 are
associated with congenital heart disease in humans. To test
whether these genes function downstream of tbx1 to regulate
zebrafish heart development, we analyzed the expression of these
tbx genes in the tbx12/2 mutant. By ISH analysis, all these genes
are more highly expressed in the ventricle as compared to the
atrium in WT embryos at 52 hpf. However, these genes are
Figure 3. Regional differentiation defects in tbx12/2 mutants. 48 hpf embryos stained for region-specific markers (A–H) and their schematic
representation (I–L). Red lines indicate myocardium, grey lines indicate endocardium and blue lines indicate gene expression. bmp4 (OFT, AVC and
IFT), notch1b (AVC endocardium) and versican (AVC myocardium) expression is down-regulated in tbx12/2 mutants (E–G) as compared to WT siblings
(A–C). The insets in C and G show versican expression in the ear as a control for ISH. anf expression is localized to the outer parts of the chamber
myocardium in WT (D), but is broadly expressed in the ventricle and atrium in tbx12/2 mutants (H). Arrows point to the AVC in all panels; v, ventricle;
a, atrium. The plots in M–P show the penetrance of the phenotype as percentage embryos with absent/mis-localized expression of the respective
gene. N depicts the total number of embryos represented in the plot. Scale bars: 50 mm.
doi:10.1371/journal.pone.0058145.g003
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unaffected in the tbx12/2 mutants (Fig. S5A–D, F–I), suggesting
that they are not regulated by tbx1.
Another important gene that regulates heart development and
looping is Wnt11. In spite of similarity in cardiac phenotype of
Tbx12/2 and Wnt112/2 mouse mutants, no link between these
genes has been established to date. While zebrafish wnt11r is
homologous to Xenopus wnt11r, and Xenopus wnt11r has been
implicated in heart looping [15], the role of zebrafish wnt11r in
heart development and looping has not been studied to date. We
sought to test whether wnt11 may function in the tbx1 pathway
using zebrafish mutants. Hence we first studied heart development
in the zebrafish wnt11r2/2 mutant [55]. cmcl2 ISH revealed that
the wnt11r2/2 mutants also have straight hearts, similar to
tbx12/2 mutants (Fig. 5A). Quantification of angle between the
ventricular and atrial axes revealed that the looping angle is
significantly reduced to 10u in wnt11r2/2 mutants from 19u in WT
siblings.
Next, we analyzed the regional differentiation in wnt11r2/2
hearts. Similar to tbx12/2 mutants (Fig. 3), wnt11r2/2 mutants
have unchanged ventricular and atrial differentiation (data not
shown). However, similar to tbx12/2 mutants (Fig. 3), wnt11r2/2
mutants have down-regulated bmp4, versican and notch1b (Fig. 5C).
Additionally, expression of anf is expanded to the inner curvature
especially in the ventricle (Fig. 5C). Staining with DAF-2DA and
eln2 ISH reveal that wnt11r2/2 mutants do not have BA defects
(Fig. S6), suggesting that the heart looping and regional
differentiation defects are independent of BA defects. Together,
the heart looping and regional differentiation defects observed in
wnt11r2/2 mutants indicate that wnt11r may function downstream
of tbx1 during these processes.
tbx1 and wnt11r function in the same pathway to
regulate heart looping and regional differentiation
The expression of wnt11r in zebrafish heart development in
zebrafish is unknown. Our ISH analysis revealed that wnt11r is first
expressed in cardiac mesoderm just prior to fusion (21 somites,
Fig. 6A) and after tbx1 expression in the heart begins. wnt11r
expression is maintained in cardiomyocytes in both the atrium and
the ventricle as the heart forms and loops (Fig. 6B). Over time,
wnt11r expression weakens throughout the heart, although it is still
present as late as 48 hpf (Fig. 6C). The expression of wnt11r in the
heart correlates with the straight heart defect in wnt11r2/2
mutants. Furthermore, the initiation of wnt11r expression after the
onset of tbx1 expression in cardiac progenitors supports the
possibility that that tbx1 initiates heart expression of wnt11r.
To assess whether tbx1 regulates wnt11r during heart develop-
ment we analyzed wnt11r expression in tbx1 knockdowns. If tbx1
Figure 4. Bulbous arteriosus defects in tbx12/2 embryos. Dissected hearts from 72 hpf embryos showing the BA region (A, D) outlined in
white, with the bidirectional arrowheads in black and red showing the length and width of BA, respectively. (B, E) The corresponding images showing
staining for Alcama antibody (red) and DAF-2DA (green). (C, F) tbx12/2 mutants at the same stage have absent eln2 expression. Black arrows indicate
the BA. (G) Quantification of BA width in WT and tbx12/2 mutants, while (H) demonstrates that BA length is reduced in tbx12/2 mutants; * p-
value = 0.0045. N = 13 for all measurements. Scale bars: 25 mm.
doi:10.1371/journal.pone.0058145.g004
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activates wnt11r expression, we would expect a decrease in wnt11r
signal in the absence of tbx1. Indeed, we observed that wnt11r
expression is down-regulated in tbx12/2 mutants (Fig. S5E, J and
6D, E). This result was corroborated by quantitative RT-PCR,
which indicates that wnt11r RNA is down-regulated by 37% in
hearts of tbx12/2 mutants (not shown). In contrast, tbx1 expression
is unchanged in wnt11r2/2 mutants as compared to WT siblings
(Fig. 7A, C). The defective heart looping and regional differen-
tiation defects of wnt11r2/2 mutants, the timing and location of
wnt11r expression with respect to tbx1 expression, and the
reduction of wnt11r in tbx12/2 mutant larvae all support our
hypothesis that tbx1 regulates heart looping and regional
differentiation through wnt11r.
To further explore this hypothesis we conducted non-allelic
non-complementation assays. tbx1+/2 and wnt11r+/2 heterozy-
gotes have unaffected cardiac looping and regional differentiation
(Fig. 6F, G). We crossed tbx1+/2 and wnt11r+/2 mutants and
analyzed the double heterozygous larvae. Our analysis reveals that
tbx1+/2;wnt11r+/2 larvae have incomplete looping and fail to
express notch1b in significantly more larvae as compared to tbx1+/2
or wnt11r+/2 larvae (Fig. 6F, G). The penetrance of defects in
tbx1+/2;wnt11r+/2 is slightly lower than tbx12/2 or wnt11r2/2
mutants, but the resulting phenotype is the same. Thus the double
heterozygote carrying recessive mutations in tbx1 and wnt11r
exhibits a phenotype similar to homozygous mutant of either gene,
while single heterozygotes do not. These double-heterozygote
analyses indicate a case of non-allelic non-complementation and
suggest that tbx1 and wnt11r function in the same pathway to
regulate heart looping and regional differentiation.
tbx1 regulates heart looping and regional differentiation
via wnt11r and alcama in a linear pathway
Previous work identified Xenopus alcama as a downstream target
of wnt11r during differentiation of cardiomyocytes and heart
looping [16]. This led us to propose tbx1 regulates heart looping
and differentiation by activating wnt11r, which in turn activates
alcama. We tested our hypothesis by analyzing Alcama expression
during heart development. alcama expression starts in the heart
progenitors at 21 somites and continues on until 4 dpf [56,57].
Similar to tbx1 expression, Alcama protein expression is stronger in
the ventricle than atrium and is prominent in the AVC in WT
embryos (Fig. 7B, E). However in both tbx12/2 and wnt11r2/2
mutants, Alcama expression is strongly down-regulated in
ventricles and weakly down-regulated in atria at 48 hpf (Fig. 7D,
F), supporting our hypothesis that alcama is downstream of tbx1 and
wnt11r.
To test the specific function of alcama during zebrafish heart
morphogenesis, we injected a morpholino directed against alcama
[40] into zebrafish at the 1-cell stage and assessed heart looping
and regional differentiation at 48 hpf. alcama morphants have
defective heart looping of varying severity (Fig. 7H), a finding that
may be explained by dosage differences in morpholino injections.
In addition to looping defects, alcama morphants have defects in
regional differentiation of the heart as assessed by notch1b ISH
(Fig. 7J). Furthermore, in accordance with our hypothesis that
alcama functions downstream of tbx1 and wnt11r, their expression is
unaffected in alcama morphants (data not shown). Hence, we have
shown that Alcama is down-regulated in tbx12/2 and wnt11r2/2
mutants, and that alcama is needed for normal heart looping and
differentiation.
Figure 5. Heart looping and regional differentiation defects in wnt11r2/2 mutants. (A) cmlc2 ISH showing the looping defect in wnt11r2/2
mutants. (B) Atrio-ventricular axis angle in wild-type (left, green) and wnt11r2/2mutants (right, blue). N indicates the total number of embryos from 3
experiments. (C) Defective regional differentiation of heart in wnt11r2/2 mutants, similar to those seen in tbx12/2 mutants. Scale bars: 50 mm.
doi:10.1371/journal.pone.0058145.g005
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We further tested whether wnt11r and alcama function down-
stream of tbx1 by rescue experiments. If cardiac defects in tbx12/2
mutants are caused specifically by suppression of the wnt11r-alcama
pathway, ectopic expression of wnt11r or alcama should rescue
cardiac defects in tbx12/2 mutants. We injected wnt11r or alcama
RNA into 1-cell stage tbx12/2 mutants at concentrations that do
not produce a phenotype in WT embryos (see methods). Injected
mutants were assessed for heart looping (cmlc2 ISH, Fig. 8B) at
52 hpf. tbx1 RNA was injected as a positive control for rescue.
Injection of either wnt11r RNA or alcama RNA increased the angle
between the ventricular and atrial axes to nearly WT levels (18u in
RNA injected tbx12/2 mutants versus 9u in uninjected tbx12/2
mutants and 23u in WT) (Fig. 8C). This data demonstrates that
wnt11r and alcam do indeed function downstream of tbx1 to
regulate heart looping in zebrafish. Similarly, mutants were
assessed for regional differentiation defects (notch1b ISH, Fig. 8E)
following injection of wnt11r or alcama RNA. Injection of either
RNA decreased the percentage of larvae with absent notch1b
staining (Fig. 8F). Partial rescue of tbx12/2 mutants by RNA
injection substantiates our model whereby tbx1, wnt11r and alcama
function in a linear pathway regulating zebrafish cardiac
development. Partial rescue can be explained by differences in
dosage and timing of expression, degradation of RNA by late
stages, or other downstream targets of tbx1 that remain unexplored
to date. These data taken together with our expression analysis
support our hypothesis whereby tbx1 activates wnt11r, which then
activates alcama to regulate heart looping and differentiation
(Fig. 8G).
Discussion
tbx1 is required for heart formation, cardiomyocyte
shape and differentiation
Tbx1 has been identified as the gene critical for regulating DGS
etiology However, the molecular and cellular defects caused by
loss of tbx1 have not been well characterized. Using the zebrafish
tbx12/2 mutant, we have demonstrated that similar to mice,
zebrafish tbx1 is required for normal heart development. Zebrafish
tbx12/2 mutants have improperly looped hearts, undifferentiated
BA and other morphological defects. These defects may be a
milder presentation of the conotruncal defects and ventricular
septal defects in DGS patients and mouse Tbx12/2 mutants.
Indeed, genes regulating zebrafish heart looping such as Bmp4,
Tbx2, Tbx3, Tbx5, Tbx20, and Wnt11r, are associated with
conotruncal defects in humans or mice, but not looping defects
[58,59,60,61,62].
Furthermore, data indicates that OFT defects result from a
failure of OFT myocardial wall to rotate [63], suggesting that
myocardial wall rotation might be the final stage of the looping
process that is affected in mouse mutants and DGS patients. This
would explain the intersection of genes involved in the two
processes. Hence, improper looping and BA morphology in
zebrafish may be a milder presentation of the conotruncal defects
in DGS patients. Our data reveals a new role for tbx1 in regulating
heart looping thereby contributing to the conotruncal and septal
development of the heart. This may provide a new mechanism by
which loss of Tbx1 contributes to conotruncal cardiac defects in
DGS.
Figure 6. wnt11r and tbx1 cooperate to regulate heart looping and differentiation. (A–C) ISH showing wnt11r expression in the fusing heart
fields (21 somites, A), linear heart tube (24 hpf, B) and fully looped heart (48 hpf, C) in WT embryos. (D, E) Dissected hearts from WT (D) versus tbx12/2
mutant (E) embryos stained for wnt11r expression at 48 hpf. The heart boundaries are indicated by dotted lines. Arrows point to the AVC. Scale bars:
50 mm. (F, G) Quantification of penetrance of looping and regional differentiation defects in double heterozygotes as compared to single
heterozygotes of tbx1 and wnt11r. WT is shown as negative control, and tbx12/2 and wnt11r2/2 mutants as positive control for looping and regional
differentiation defects. N depicts the total number of embryos from 3 experiments.
doi:10.1371/journal.pone.0058145.g006
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The looping defect, taken together with the weaker ventricular
contractions and slower heart rate in tbx12/2 mutants, suggests
that tbx1 is required for proper heart formation. Despite the defects
in heart formation, the early stages of cardiogenesis proceed
normally in tbx1 mutants. Atrial and ventricular fates are assigned
normally in the tbx12/2 mutant as indicated by normal cmcl2, vmhc
and amhc ISH staining (Fig. 1, S3), and normal antibody staining
for S46 and MF20 (data not shown). Given the expression of tbx1
in cardiac mesodermal progenitors from the fusion stage (Fig.
S1A), this finding was surprising. However, it is consistent with
mouse data [12] and suggests that tbx1 is not required for heart
specification and early development.
While cells are specified properly our data show that cell shape
is disrupted in tbx1mutants. In tbx12/2mutants cells fail to change
from isotropic to anisotropic shape in the outer curvature. Other
zebrafish mutants/morphants with looping defects share the
observed defects in cell shape [46,50,52]. This cell shape defect
combined with reduction in cell number may contribute to looping
defects by changing cell-cell interaction. Indeed, cross-sections of
tbx12/2 mutant hearts reveal an increase in extracellular spaces
compared to WT siblings. This observation is important, as
increased extracellular spaces have been observed in wnt11r and
alcama morphants in Xenopus [15,16]. Decreased cell adhesion due
to down-regulation of the adhesion molecule alcama, may be
causing the increase in extracellular spaces in tbx12/2 mutants.
Alternatively, the increased extracellular spaces may lead to
altered cell polarity or may preclude changes in cell shape or
differentiation. These data indicate that tbx1 is required for
induction of morphological, proliferative and shape changes in
cardiomyocytes.
An additional factor contributing to the heart defects observed
in tbx12/2 is a loss of tissue differentiation. Cardiomyocytes fail to
differentiate into the OFT and AVC as indicated by down
regulation of bmp4, versican and notch1b. In addition mis-expression
of anf also corroborates this conclusion. Absent expression of bmp4,
versican and notch1b in tbx12/2 mutants is in striking contrast to
other looping mutants, where these markers fail to be restricted to
their respective domains [46,49,50,52]. Hence we propose that
tbx1 regulation of heart looping is distinct from genes such as tbx2a,
tbx3b and nkx2.5, which also regulate this process. An unresolved
question is whether differentiation of the heart regions contributes
to looping or vice versa.
tbx1 regulates differentiation of the SHF and BA
DGS patients and Tbx12/2 mice have OFT defects such as
persistent truncus arteriosus [2]. Moreover, Tbx1 is expressed in
the mouse SHF and regulates SHF contribution to the OFT [12].
The zebrafish SHF has been recently described [31,32] but tbx1
expression in SHF cells has not been described so far. However,
similarly to data in mouse, zebrafish tbx12/2 mutants have a
smaller BA, indicating decreased contribution of SHF to the
arterial pole of the heart. In addition, absent eln2 expression and
DAF-2DA staining indicates that smooth muscle in the BA is
undifferentiated. In addition to the BA, the ventricle in tbx12/2
mutants is also small and dysmorphic, with a severe reduction in
total cardiomyocyte number. While our investigation of the BA
defect in tbx12/2 mutants was ongoing, absence of tbx1 was
reported to reduce differentiation and incorporation of SHF-
derived cells to the arterial pole of the heart [32]. These results are
complementary to our data, indicating that tbx1 is required for
SHF cell incorporation into the BA and subsequent differentiation
of smooth muscle cells.
Reduced incorporation of cardiomyocytes from the SHF in
zebrafish tbx12/2 mutant hearts suggests that the processes
involved in heart development are conserved through evolution.
Furthermore, the BA defects in zebrafish are consistent with
conotruncal and septal defects observed in DGS patients and
Tbx12/2 mice. However, as opposed to humans and mice,
zebrafish do not develop ventricular hypertrophy as a compensa-
tory mechanism to outflow tract defects. The defects in looping,
differentiation, and heart rate emerge at 48 hpf, before the first
detectable time point for outflow tract defect (72 hpf), suggesting
that the ventricular defect is not secondary to the outflow tract
defect.
While Tbx1’s role in regulating proliferation and contribution of
SHF cells has been studied [12], our data reveals a role for tbx1 in
regulating heart looping. We postulate that the conotruncal and
septal defects in DGS may be a more severe manifestation of the
defects in SHF cell incorporation and the defects in morphological
movements of looping during development.
wnt11r functions downstream of tbx1
Although Wnt11 signaling has been shown to be important for
specification of cardiac fate and Wnt112/2 mutants have OFT
defects [19,20,25], Tbx1 and Wnt11 signaling pathways have not
Figure 7. tbx1 and wnt11r regulate Alcama levels, and alcama
regulates heart looping and differentiation. (A, C) ISH analysis on
48 hpf embryos showing that wnt11r2/2 mutants have unaffected tbx1
expression. (B, D, E, F) Antibody staining showing that wnt11r2/2 (D)
and tbx12/2 (F) mutants have down-regulated Alcama expression when
compared to WT siblings (B, E). cmlc2 ISH on 48 hpf embryos showing
the various looping phenotypes observed in alcama morphants (H) and
proper looping in an uninjected larva (G). notch1b is expressed in the
AVC endocardium in an uninjected larva at 48 hpf (I), but is down-
regulated in alcama morphants (J). Scale bars: 50 mm.
doi:10.1371/journal.pone.0058145.g007
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been linked to date. Unlike mouse and chicken embryos, Xenopus
and zebrafish embryos do not express wnt11 in the developing
heart [15]. wnt11r, a second wnt11 gene in Xenopus and zebrafish,
with high homology to human and chicken Wnt11, mediates non-
canonical Wnt signaling and is necessary for normal heart
morphogenesis. In Xenopus, wnt11r starts to be expressed just prior
to fusion of cardiac progenitors and subsequently continues to be
expressed in the heart tissue. It was later discovered that alcama
regulates cardiac looping and functions downstream of wnt11r in
Xenopus [16].
The role of wnt11r in zebrafish heart morphogenesis has not
been previously characterized. We show that similarly to Xenopus,
zebrafish wnt11r is first expressed at 21somites just prior to cardiac
progenitor fusion and continues to be expressed as the heart
develops. Our data shows that wnt11r2/2 mutants have similar
looping and regional differentiation defects as observed in tbx12/2
mutants, and that wnt11r is down-regulated in tbx12/2 mutant
hearts. Furthermore, our non-allelic non-complementation assay
indicates that tbx1 and wnt11r function in the same pathway.
Knockdown of alcama, a gene demonstrated to be downstream of
wnt11r, also presents with looping and regional differentiation
defects. Importantly, we were able to rescue the looping and
differentiation defects in tbx12/2 mutants by injection of wnt11r
and/or alcama RNA. All these data lead us to our working model
that tbx1 regulates wnt11r, wnt11r regulates alcama, which in turn
regulates heart looping and differentiation (Fig. 8G). Elucidation of
new players in the pathway may help in developing future
therapies for patients with DGS and other cardiac defects.
Conclusions
In summary, this study demonstrates that zebrafish tbx12/2
mutants have defects in heart looping and function. This is the first
demonstration that tbx1 regulates differentiation and shape of
cardiac cells derived from PHF. In addition, we describe tbx1’s role
in regulating total cardiomyocyte number via PHF cell prolifer-
ation that may be compounded by lack of contribution of SHF
cells in tbx12/2 mutants. Importantly, we have identified wnt11r
and alcama as novel mediators of the tbx1 pathway. We show for
the first time that in zebrafish wnt11r2/2 mutants and alcama
morphants have heart looping and differentiation defects similar to
tbx12/2 mutants, and our expression and non-complementation
assay confirms that wnt11r and tbx1 function in the same pathway.
Moreover, these defects can be rescued by over-expression of
wnt11r and/or alcama in tbx12/2 mutants, suggesting that they
function downstream of tbx1. Our data support a model whereby
tbx1 regulates heart looping and differentiation via wnt11r and
alcama. These findings are an important contribution to our
understanding of tbx1 signaling and heart development.
Figure 8. tbx1 functions through wnt11r to regulate heart looping and regional differentiation. ISH for cmlc2 (A, B) and notch1b (D, E)
showing rescue of looping (B) and regional differentiation defect (E) at 48 hpf after injection of 26 pg wnt11r RNA at the 1-cell stage. Plots in C and F
quantify the rescue of looping and regional differentiation defect after the indicated injections. WT siblings are represented in green and uninjected
tbx12/2 mutants in pink, with injected mutants in dark pink or red. Scale bars: 50 mm. N indicates the total number of embryos from 3 experiments.
(G) Outline of the working model, where tbx1 regulates wnt11r; wnt11r regulates alcama, which in turn regulates heart looping and regional
differentiation. tbx1 regulates migration/differentiation of SHF cells by an independent mechanism.
doi:10.1371/journal.pone.0058145.g008
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Supporting Information
Figure S1 tbx1 expression and heart shape defect of
tbx12/2 1arvae. ISH for tbx1 in WT embryos showing
expression in the fusing heart fields (21 somites, A), linear heart
tube (24 hpf, B) and the looped heart (48 hpf, C). A and B are
dorsal views and C is a head-on view. Arrowheads in A and B
point towards pharyngeal pouches and the cardiac cells are
outlined in A–C. (D) Schematic of head-on view of 48 hpf heart.
Arrow indicates the AVC; a, atrium; v, ventricle. Dotted red lines
indicate the widths at the ends and at the widest part of the
ventricle and atrium. The longitudinal axes (shown in green) were
drawn by joining the midpoints m and n in ventricle and
midpoints p and q in atrium. mo and pr were measured for length
of ventricle and atrium, respectively (see Materials for details). (E)
Measurement of lengths of the ventricle and atrium in WT and
tbx12/2 mutants. (F, G) Measurement of the widths of the
ventricles at 48 hpf and atriums at 72 hpf in tbx12/2 mutants and
WT siblings in the expanded and contracted states. WT siblings
are represented in green and tbx12/2 mutants in pink. N indicates
the total number of embryos represented in the plot. Scale bars:
50 mm.
(TIF)
Figure S2 Proliferation defects in tbx12/2 mutants. (A,
B) Confocal projections of hearts from cmlc2:gfp (all heart cells are
green) embryos at 33 hpf stained with phospho-histone 3 antibody
(proliferating cells are red). The insets in A and B show a
magnified view of a co-labeled cell (yellow). (C, D) Plots showing
the total (C) and proliferating (D) number of cells in WT and
tbx12/2 mutants. N is the total number of embryos. Arrows point
to the AVC; v, ventricle; a, atrium. Scale bar: 25 mm.
(TIF)
Figure S3 Chambers are specified correctly in tbx12/2
mutants. ISH analysis at 48 hpf for vmhc (A, C) and amhc (B, D)
shows that the chambers are correctly specified in
tbx12/2mutants. The dotted lines indicate the heart boundary.
Scale bars: 50 mm.
(TIF)
Figure S4 tbx12/2 embryos have defects in heart
performance. (A) Measurement of ventricular contractility as
shortening fraction [(width at diastole – width at systole)/width at
diastole] shows no difference between WT and tbx12/2 embryos.
(B) Determination of atrium contractility between WT and
tbx12/2 embryos. The stroke volume (ventricular volume [diastole
– systole]) plotted in C is unaffected in tbx12/2 embryos, but the
heart rate is decreased, shown in D. N=19 in all experiments. WT
siblings are represented in green and tbx12/2 mutants in pink. p-
values are reported under each measurement.
(TIF)
Figure S5 Candidate gene analysis for tbx12/2mutants.
Whole mount lateral views (A, B, F, G) and head-on views (C–E,
H–J) of 48 hpf embryos stained for known genes that affect heart
looping. Expression of tbx2a (A, F), tbx3b (B, G), tbx5 (C, H) and
tbx20 (D, I) was unaffected between WT siblings and tbx12/2
mutants. (E, J) Dissected hearts from 48 hpf embryos show down-
regulated expression of wnt11r in the mutant (J) versus WT (E).
The heart boundary is shown by the red dotted line. Arrows point
to the AVC. Scale bars: 50 mm.
(TIF)
Figure S6 Unaffected BA in wnt11r 2/2 mutants. (A, B)
Lateral and ventral views of 72 hpf larva showing normal eln2 and
DAF-2DA staining respectively in wnt11r2/2 mutants. Scale bars:
50 mm.
(TIF)
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